Company's BV blood test to distinguish between bacterial and viral infections recently cleared by FDA; investors include Hong Kong's Horizons Ventures

Purpose of test is to tell physicians whether body is waging war on bacteria or virus, and make decisions about whether to treat with antibiotics

People who tested positive give a drop of blood, wait 15 minutes, and discover their coronavirus destiny; if severe, doctors empowered to avert the outcome

Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections